I'm not sure how long it takes for Ema to respond.. Anyway it hasn't been submitted at the time of the annual report, who knows of it has since then
From annual report :
"The US Food and Drug Administration (FDA) currently has a partial clinical hold on PBT2 that limits the dose that can be administered in trials in the US. In response, we have submitted a strong technical and safety data package, incorporating our Phase 3 HD trial design in support of lifting the hold. Concurrently, we are creating a comprehensive non-clinical and clinical package of data on PBT2 for submission to selected European national authorities and the European Medicines Agency."
Note, the fda has 30 days to respond but they can just say "need more info" .. Which prana would have to spend time preparing again.. Hoping that arent sent down take home again but I'm curbing my enthusiasm until we get news
(but still can't help get excited at thought that there is a chance we can get an announcement about hold being lifted this week )
- Forums
- ASX - By Stock
- ATH
- Dr. Tanzi Comments
Dr. Tanzi Comments, page-29
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $18.45K | 6.153M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 112553933 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 140078273 | 50 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 112553933 | 0.002 |
27 | 138410148 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 140078273 | 50 |
0.005 | 15696205 | 18 |
0.006 | 17812414 | 17 |
0.007 | 52406651 | 23 |
0.008 | 39320994 | 30 |
Last trade - 11.42am 18/10/2024 (20 minute delay) ? |
Featured News
BM8
Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
ATH (ASX) Chart |